search
Back to results

Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?

Primary Purpose

Osteoarthritis, Post-traumatic; Arthrosis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
methylprednisolone acetate
active comparator
Sponsored by
New Lexington Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Osteoarthritis focused on measuring arthroplasty, replacement, knee

Eligibility Criteria

18 Years - 95 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Between ages of 18 and 95
  • Has elected to undergo total knee replacement

Exclusion Criteria:

  • Allergy to any of the medications used in the protocol
  • History of kidney disease
  • Rheumatoid arthritis
  • Any systemic conditions associated with chronic pain
  • History of deep knee sepsis in the affected extremity
  • Unable to understand the questions used to obtain the Knee Society Score
  • Minors and prisoners will be excluded from the study

Sites / Locations

  • Lexington Clinic Sports Medicine Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control

Corticosteroid

Arm Description

Patients in the active comparator group will receive intraoperative injections containing bupivacaine HCl, morphine, epinephrine, clonidine, cefuroxime, and normal saline, as per the surgeon's standard of care.

Patients in the Corticosteroid group will have the same medications as the Control Group with the addition of a corticosteroid (methylprednisolone acetate)

Outcomes

Primary Outcome Measures

Length of Hospital Stay
Knee Range of Motion
Knee Society Scores
The Knee Society Score is on a scale of 0 to 100, with 0 being the worst possible score, and 100 being the best possible score. The Knee Society Score takes into account subjective patient reports of pain and functional ability as well as clinical measures of passive knee range of motion.
Amount of Pain Medication Taken Per Day
Patient Satisfaction
Complications, Such as Infections, Hospital Readmissions, Manipulations Under Anesthesia, Etc.

Secondary Outcome Measures

Full Information

First Posted
June 25, 2007
Last Updated
October 29, 2013
Sponsor
New Lexington Clinic
Collaborators
St. Joseph's Health Care London
search

1. Study Identification

Unique Protocol Identification Number
NCT00492973
Brief Title
Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
Official Title
Peri-articular Injections Containing a Corticosteroid During Total Knee Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
March 2006 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
February 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
New Lexington Clinic
Collaborators
St. Joseph's Health Care London

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.
Detailed Description
Information collected during your office visits: The patient will be asked for a brief medical history so that we may determine if the patient can participate in the study. A member of our research team will ask the patient a series of questions about his/her knee. The patient will be asked to answer this series of questions a total of 4 times over the course of 1 year. Also, we will record how well the patient can bend and straighten your knee at these 4 office visits. We will have the patient rate the pain in his/her knee and ask the patient if he/she is satisfied with the surgery. If the patients have any complications, those will also be recorded. The patient will also have X-rays taken of the knee at the postoperative follow-up visits. This is the normal routine following total knee replacement. The X-rays will be read by the surgeon to help determine the success of the surgery. Injection during total knee replacement surgery: All patients will receive an injection containing bupivicaine HCl, morphine, epinephrine, clonidine, cefuroxime, and normal saline that will be placed directly into the knee during surgery. In addition, approximately half of the patients in the study will also receive methylprednisolone acetate as part of the injection. Information being collected during your hospital stay: During the hospital stay, information will be gathered for this study. A physical therapist will measure how well the patient can bend and straighten the knee. The amount of pain medication that was taken at the hospital will be recorded, and the number of days spent in the hospital will also be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Post-traumatic; Arthrosis
Keywords
arthroplasty, replacement, knee

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
101 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Description
Patients in the active comparator group will receive intraoperative injections containing bupivacaine HCl, morphine, epinephrine, clonidine, cefuroxime, and normal saline, as per the surgeon's standard of care.
Arm Title
Corticosteroid
Arm Type
Experimental
Arm Description
Patients in the Corticosteroid group will have the same medications as the Control Group with the addition of a corticosteroid (methylprednisolone acetate)
Intervention Type
Drug
Intervention Name(s)
methylprednisolone acetate
Intervention Description
Same medications and doses as the active comparator, but with the addition of 40 mg of methylprednisolone acetate
Intervention Type
Drug
Intervention Name(s)
active comparator
Other Intervention Name(s)
bupivacaine HCl, morphine, epinephrine, clonidine, cefuroxime, normal saline
Intervention Description
bupivacaine HCl 80 mg, morphine 4 mg, epinephrine 300 micrograms, clonidine 100 micrograms, cefuroxime 750 mg, and normal saline
Primary Outcome Measure Information:
Title
Length of Hospital Stay
Time Frame
days after surgery
Title
Knee Range of Motion
Time Frame
3 months
Title
Knee Society Scores
Description
The Knee Society Score is on a scale of 0 to 100, with 0 being the worst possible score, and 100 being the best possible score. The Knee Society Score takes into account subjective patient reports of pain and functional ability as well as clinical measures of passive knee range of motion.
Time Frame
3 months postoperative
Title
Amount of Pain Medication Taken Per Day
Time Frame
Average of 3 days after surgery
Title
Patient Satisfaction
Time Frame
6 weeks, 3 months, and 1 year postoperative
Title
Complications, Such as Infections, Hospital Readmissions, Manipulations Under Anesthesia, Etc.
Time Frame
any point during the first postoperative year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between ages of 18 and 95 Has elected to undergo total knee replacement Exclusion Criteria: Allergy to any of the medications used in the protocol History of kidney disease Rheumatoid arthritis Any systemic conditions associated with chronic pain History of deep knee sepsis in the affected extremity Unable to understand the questions used to obtain the Knee Society Score Minors and prisoners will be excluded from the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian P Christensen, MD
Organizational Affiliation
New Lexington Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lexington Clinic Sports Medicine Center
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40504
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
15534532
Citation
Lombardi AV Jr, Berend KR, Mallory TH, Dodds KL, Adams JB. Soft tissue and intra-articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop Relat Res. 2004 Nov;(428):125-30. doi: 10.1097/01.blo.0000147701.24029.cc.
Results Reference
background
PubMed Identifier
17472300
Citation
Parvataneni HK, Ranawat AS, Ranawat CS. The use of local periarticular injections in the management of postoperative pain after total hip and knee replacement: a multimodal approach. Instr Course Lect. 2007;56:125-31.
Results Reference
background
PubMed Identifier
19884426
Citation
Christensen CP, Jacobs CA, Jennings HR. Effect of periarticular corticosteroid injections during total knee arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am. 2009 Nov;91(11):2550-5. doi: 10.2106/JBJS.H.01501.
Results Reference
derived

Learn more about this trial

Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?

We'll reach out to this number within 24 hrs